Chardan Capital raises Taysha Gene PT to $12, maintains Buy rating.

miércoles, 5 de noviembre de 2025, 7:49 am ET1 min de lectura
TSHA--

Chardan Capital raises Taysha Gene PT to $12, maintains Buy rating.

Chardan Capital raises Taysha Gene PT to $12, maintains Buy rating.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios